Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 May 2024 | Story Anthony Mthembu | Photo Sanchay Kalicharan
EMS research symposium 2024
Pictured at the research symposium from left to right: Cornelle Scheltema-Van Wyk, Deputy Director at the Library and Information Services at UFS; Prof Lochner Marais, Professor at the Centre for Development Support at UFS; Prof Brownhilder Neneh, Vice-Dean: Research, Engagement and Internationalisation in the EMS faculty at UFS; Prof Nicolene Barkhuizen, Director of the Business School at UFS; Prof Betty Mubangizi, Professor from the University of Kwa-Zulu Natal; and Prof Phillipe Burger, Dean of the EMS faculty at UFS.

The Faculty of Economic and Management Sciences (EMS) at the University of the Free State (UFS) recently hosted a transformative research career development symposium on 24 April 2024 and 3 May 2024 at the UFS Business School, on the Bloemfontein Campus. Themed “Building the Next Generation of Researchers and Academics: developing a Body of Work within a Niche Area and Publishing in Quality Journals,” the symposium provided a pivotal platform for scholarly growth and strategic planning.

In his opening address, Prof Philippe Burger, the Dean of the EMS faculty, underscored the significance of the event, stating, “We need to be scholars who can be contacted from outside and be ambitious to be known for something; this symposium would give our staff that opportunity.”

Symposium highlights

Prof Brownhilder Neneh, Vice-Dean of Research, Engagement and Internationalisation in the EMS faculty, elucidated the symposium’s objectives, highlighting its role in fostering career development, equipping lecturers with practical insights, and fostering proactive career management. Distinguished guests from institutions nationwide graced the symposium with their expertise.

The first session, tailored for the School of Accountancy, featured luminaries in the accounting field such as Prof Elmar Venter from the University of Pretoria (UP) and Professor Belinda Le Clerq from the University of South Africa (UNISA). The subsequent session catered to lecturers and senior lecturers across the faculty, featuring presentations from esteemed academics like Prof Mercy Mpinganjira from the University of Johannesburg (UJ), Prof Sebastian (Ian) Rothmann from the North-West University (NWU), and Prof Betty Mubangizi from the University of KwaZulu Natal (UKZN). Internal speakers, including Prof Burger, Prof Lochner Marais from the Centre for Development Support (CDS) at the UFS, and Prof Nicolene Barkhuizen, Director of the Business School at the UFS, also shared insights.

Symposium value and alignment with Vision 130

Prof Neneh stressed the symposium’s alignment with Vision130. She said, ‘’Hosting this symposium demonstrates the faculty’s commitment to nurturing a research-led faculty that not only addresses local and regional problems but aligns with international standards. Prof Neneh noted that the engagement offered an invaluable opportunity for academic staff to deepen their understanding of research niche areas, the significance of publishing in high-impact journals, and the cultivation of sustainable research networks.

Throughout the symposium, presenters covered a diverse array of topics, including identifying and refining niche research areas, best practices for conducting high-impact research, overcoming publishing challenges, and strategies for enhancing visibility and citation impact.  

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept